Purchase by Wijngaard Peter of 1000 shares of Hepion Pharmaceuticals
| HEPADelisted Stock | USD 0.11 0.01 8.33% |
About 61% of Hepion Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Hepion Pharmaceuticals stock suggests that many investors are alarmed at this time. The current market sentiment, together with Hepion Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Hepion Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Hepion |
Filed transaction by Hepion Pharmaceuticals In director. General open market or private purchase of non-derivative or derivative security
Read at macroaxis.com
Hepion Pharmaceuticals Fundamental Analysis
We analyze Hepion Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hepion Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hepion Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
Hepion Pharmaceuticals is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Hepion Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hepion Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Hepion Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Hepion Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Hepion Pharmaceuticals Related Equities
| ENVB | Enveric Biosciences | 5.79 | ||||
| ZURA | Zura Bio | 1.92 | ||||
| ELEV | Elevation Oncology | 3.03 |
Check out Hepion Pharmaceuticals Hype Analysis, Hepion Pharmaceuticals Correlation and Hepion Pharmaceuticals Performance. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Hepion Stock
If you are still planning to invest in Hepion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hepion Pharmaceuticals' history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stocks Directory Find actively traded stocks across global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |